NRSN logo

NeuroSense Therapeutics (NRSN) Company Overview

Profile

Full Name:

NeuroSense Therapeutics Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

December 9, 2021

Indexes:

Not included

Description:

NeuroSense Therapeutics (NRSN) is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, such as ALS and Parkinson's. They aim to improve patients' quality of life through advanced therapies that target the underlying causes of these conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 22, 2023

Recent annual earnings:

Mar 22, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 16, 24 Maxim Group
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for NeuroSense Therapeutics?
  • Does NeuroSense Therapeutics pay dividends?
  • What sector is NeuroSense Therapeutics in?
  • What industry is NeuroSense Therapeutics in?
  • What country is NeuroSense Therapeutics based in?
  • When did NeuroSense Therapeutics go public?
  • Is NeuroSense Therapeutics in the S&P 500?
  • Is NeuroSense Therapeutics in the NASDAQ 100?
  • Is NeuroSense Therapeutics in the Dow Jones?
  • When was NeuroSense Therapeutics's last earnings report?
  • When does NeuroSense Therapeutics report earnings?
  • Should I buy NeuroSense Therapeutics stock now?

What is the ticker symbol for NeuroSense Therapeutics?

The ticker symbol for NeuroSense Therapeutics is NASDAQ:NRSN

Does NeuroSense Therapeutics pay dividends?

No, NeuroSense Therapeutics does not pay dividends

What sector is NeuroSense Therapeutics in?

NeuroSense Therapeutics is in the Healthcare sector

What industry is NeuroSense Therapeutics in?

NeuroSense Therapeutics is in the Biotechnology industry

What country is NeuroSense Therapeutics based in?

NeuroSense Therapeutics is headquartered in Israel

When did NeuroSense Therapeutics go public?

NeuroSense Therapeutics's initial public offering (IPO) was on December 9, 2021

Is NeuroSense Therapeutics in the S&P 500?

No, NeuroSense Therapeutics is not included in the S&P 500 index

Is NeuroSense Therapeutics in the NASDAQ 100?

No, NeuroSense Therapeutics is not included in the NASDAQ 100 index

Is NeuroSense Therapeutics in the Dow Jones?

No, NeuroSense Therapeutics is not included in the Dow Jones index

When was NeuroSense Therapeutics's last earnings report?

NeuroSense Therapeutics's most recent earnings report was on Mar 22, 2023

When does NeuroSense Therapeutics report earnings?

The date for NeuroSense Therapeutics's next earnings report has not been announced yet

Should I buy NeuroSense Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions